Scheduled Maintenance Notice

Please note that Researcher Profiles will be undergoing scheduled maintenance on Wednesday 7th Oct, from 8:00am to 9:00am. During this time, the Researcher Profiles system will be unavailable. We apologise for any inconvenience and appreciate your understanding.

Select Publications

Journal articles

Baldock P; Allison SJ; Sainsbury A; Enriquez R; Gardiner EM; Herzog H; Eisman JA, 2006, 'Central control of cortical bone homeostasis: Neuropeptide Y exerts a negative effect on cortical bone formation', Bone, 38, pp. S6 - S6

Stanic D; Brumovsky P; Fetissov S; Shuster S; Herzog H; Hokfelt T, 2006, 'Characterization of neuropeptide Y2 receptor protein expression in the mouse brain. I. Distribution in cell bodies and nerve terminals', Journal of Comparative Neurology, 499, pp. 357 - 390

Lin E-JD; Sainsbury A; Lee NJ; Boey D; Couzens M; Enriquez R; Slack K; Bland R; During MJ; Herzog H, 2006, 'Combined deletion of Y1, Y2, and Y4 receptors prevents hypothalamic neuropeptide Y overexpression-induced hyperinsulinemia despite persistence of hyperphagia and obesity.', Endocrinology, 147, pp. 5094 - 5101, http://dx.doi.org/10.1210/en.2006-0097

Batterham R; Heffron H; Kapoor S; Chivers J; Chandarana K; Herzog H; Le Roux C; Thomas E; Bell JD; Withers D, 2006, 'Critical role for peptide YY in protein-mediated satiation and body-weight regulation', Cell Metabolism, 4, pp. 223 - 233

Allison SJ; Baldock P; Sainsbury A; Enriquez R; During M; Eisman JA; Herzog H; Gardiner EM, 2006, 'Deletion of hypothalamic neuropeptide Y2-receptors in adult mice protects against continued ovariectomy-induced bone loss', Bone, 38, pp. S6 - S6

Lin E; Young D; Baer K; Herzog H; During M, 2006, 'Differential actions of NPY on seizure modulation via Y1 and Y2 receptors: Evidence from receptor knockout mice', Epilepsia, 47, pp. 773 - 780

Lin E-JD; Lee NJ; Slack K; Karl T; Duffy L; O'brien E; Matsumoto I; Dedova I; Herzog H; Sainsbury A, 2006, 'Distinct endocrine effects of chronic haloperidol or risperidone administration in male rats.', Neuropharmacology, 51, pp. 1129 - 1136, http://dx.doi.org/10.1016/j.neuropharm.2006.07.006

Lin S; Boey D; Lee N; Schwarzer C; Sainsbury A; Herzog H, 2006, 'Distribution of prodynorphin mRNA and its interaction with the NPY system in the mouse brain.', Neuropeptides, 40, pp. 115 - 123, http://dx.doi.org/10.1016/j.npep.2005.11.006

Karl T; Burne T; Herzog H, 2006, 'Effect of Y-1 receptor deficiency on motor activity, exploration, and anxiety', Behavioural Brain Research, 167, pp. 87 - 93

Carvajal C; Dumont Y; Herzog H; Quirion R, 2006, 'Emotional behavior in aged neuropeptide Y (NPY)Y-2 knockout mice', Journal of Molecular Neuroscience, 28, pp. 239 - 245

Baldock P; Allison SJ; Sainsbury A; Enriquez R; Gardiner EM; Herzog H; Eisman JA, 2006, 'Hypothalamic neuropeptide Y exerts a negative effect on cortical bone formation', Journal of Bone and Mineral Research, 21, pp. S65 - S65

Baldock P; Allison SJ; Mcdonald M; Sainsbury A; Enriquez R; Little DG; Eisman JA; Gardiner EM; Herzog H, 2006, 'Hypothalamic regulation of cortical bone mass: Opposing activity of Y2 receptor and leptin pathways', Journal of Bone and Mineral Research, 21, pp. 1600 - 1607

Boey D; Heilbronn L; Sainsbury-Salis A; Laybutt DR; Kriketos AD; Herzog H; Campbell LV, 2006, 'Low serum PYY is linked to insulin resistance in first-degree relatives of subjects with type 2 diabetes', Neuropeptides, 40, pp. 317 - 324

Balasubramaniam A; Mullins D; Lin S; Zhai W; Tao Z; Dhawan V; Guzzi M; Knittel J; Slack K; Herzog H; Parker E, 2006, 'Neuropeptide Y (NPY) Y-4 receptor selective agonists based on NPY(32-36): Development of an anorectic Y-4 receptor selective agonist with picomolar affinity', Journal of Medicinal Chemistry, 49, pp. 2661 - 2665

Tu B; Jiao Y; Herzog H; Nadler JV, 2006, 'Neuropeptide Y regulates recurrent mossy fiber synaptic transmission less effectively in mice than in rats: correlation with Y2 receptor plasticity', Neuroscience, 143, pp. 1085 - 1094

Boey D; Lin S; Karl T; Baldock P; Lee N; Enriquez R; Couzens M; Slack K; Dallmann R; Sainsbury A; Herzog H, 2006, 'Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity.', Diabetologia, 49, pp. 1360 - 1370, http://dx.doi.org/10.1007/s00125-006-0237-0

Wultsch T; Painsipp E; Donner S; Sperk G; Herzog H; Peskar B; Holzer P, 2006, 'Selective increase of dark phase water intake in neuropeptide-Y Y2 and Y4 receptor knockout mice', Behavioural Brain Research, 168, pp. 255 - 260

Doyle K; Hort Y; Shine J; Herzog H, 2006, 'The role of neuropeptide Y in the neuroproliferation of adult olfactory stem cells', CYTOMETRY PART A, 69A, pp. 407 - 408

Sainsbury A; Bergen HT; Boey D; Bamming D; Cooney GJ; Lin S; Couzens M; Stroth N; Lee NJ; Lindner D; Singewald N; Karl T; Duffy L; Enriquez R; Slack K; Sperk G; Herzog H, 2006, 'Y2Y4 receptor double knockout protects against obesity due to a high-fat diet or Y1 receptor deficiency in mice.', Diabetes, 55, pp. 19 - 26, https://www.ncbi.nlm.nih.gov/pubmed/16380472

Molero JC; Jensen TE; Withers PC; Couzens M; Herzog H; Thien CBF; Langdon WY; Walder K; Murphy MA; Bowtell DDL; Hardeman E; Ghoddusi M; James DE; Cooney GJ, 2005, 'Erratum: c-Cbl-deficient mice have reduced adiposity, higher energy expenditure, and improved peripheral insulin action (Journal of Clinical Investigation (2004) 114 (1326-1333) (doi:10.1172/JCI200421480))', Journal of Clinical Investigation, 115, pp. 476, http://dx.doi.org/10.1172/JCI200521480C1

Wheway JE; MacKay CR; Newton R; Sainsbury A; Boey D; Herzog H; Mackay F, 2005, 'A fundamental bimodal role for neuropeptide Y1 receptor in the immune system', Journal of Experimental Medicine, 202, pp. 1527 - 1538

Baldock P; Allison SJ; Sainsbury A; Enriquez R; Herzog H; Gardiner EM; Eisman JA, 2005, 'Central regulation of cortical bone: Opposing effects of Y2 receptor and leptin pathways', Journal of Bone and Mineral Research, 20, pp. S413 - S414

Lin S; Boey D; Couzens M; Lee N; Sainsbury A; Herzog H, 2005, 'Compensatory changes in [125I]-PYY binding in Y receptor knockout mice suggest the potential existence of further Y receptor(s).', Neuropeptides, 39, pp. 21 - 28, http://dx.doi.org/10.1016/j.npep.2004.10.002

Painsipp E; Wultsch T; Sperk G; Herzog H; Holzer R, 2005, 'Differential changes in stress-induced hyperthermia, depression-like behaviour and defaecation by NPY-Y2 and-Y4 receptor gene knockout', Behavioural Pharmacology, 16, pp. S90 - S90

Wultsch T; Painsipp E; Thoeringer C; Herzog H; Sperk G; Holzer P, 2005, 'Endogenous neuropeptide Y depresses the afferent signaling of gastric acid challenge to the mouse brainstem via neuropeptide Y type Y2 and Y4 receptors', Neuroscience, 136, pp. 1097 - 1107

Molero JC; Jensen T; Withers P; Couzens M; Herzog H; Thien C; Langdon WY; Walder K; Murphy M; Bowtell D; Hardeman E; Ghoddusi M; James DE; Cooney GJ, 2005, 'Erratum: c-Cbl-deficient mice have reduced adiposity, higher energy expenditure,and improved peripheral insulin action (vol 114, pg 1326, 2004)', Journal of Clinical Investigation, 115, pp. 476 - 476, http://dx.doi.org/10.1172/JCI21480C1

Baldock P; Sainsbury A; Allison SJ; Lin E; Couzens M; Boey D; Enriquez R; During M; Herzog H; Gardiner EM, 2005, 'Hypothalamic control of bone formation: Distinct actions of leptin and Y2 receptor pathways', Journal of Bone and Mineral Research, 20, pp. 1851 - 1857

Howell O; Doyle KL; Goodman J; Scharfman H; Herzog H; Pringle A; Beck-Sickinger A; Gray W, 2005, 'Neuropeptide Y stimulates neuronal precursor proliferation in the post-natal and adult dentate gyrus', Journal of Neurochemistry, 93, pp. 560 - 570

Brumovsky P; Stanic D; Shuster S; Herzog H; Villar M; Hokfelt T, 2005, 'Neuropeptide Y2 receptor protein is present in peptidergic and nonpeptidergic primary sensory neurons of the mouse', Journal of Comparative Neurology, 489, pp. 328 - 348

Lang R; Berger A; Santic R; Geisberger R; Hermann A; Herzog H; Kofler B, 2005, 'Pharmacological and functional characterization of galanin-like peptide fragments as potent galanin receptor agonists', Neuropeptides, 39, pp. 179 - 184

Wultsch T; Painsipp E; Peskar B; Sperk G; Herzog H; Holzer R, 2005, 'Selective increase of dark-phase water intake in NPY-Y2 and-Y4 receptor knockout mice', Behavioural Pharmacology, 16, pp. S68 - S68

El Bahh B; Balosso S; Hamilton T; Herzog H; Beck-Sickinger A; Sperk G; Gehlert D; Vezzani A; Colmers W, 2005, 'The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y-2 and not Y-5 receptors', European Journal of Neuroscience, 22, pp. 1417 - 1430

Wittmann W; Loacker S; Kapeller I; Herzog H; Schwarzer C, 2005, 'Y1-receptors regulate the expression of Y2-receptors in distinct mouse forebrain areas', Neuroscience, 136, pp. 241 - 250

Baldock P; Allison SJ; Sainsbury A; Enriquez R; Herzog H; Eisman JA; Gardiner EM, 2005, 'Y2 receptors and the central regulation of cortical bone: Reciprocal activity to leptin', Bone, 36, pp. S142 - S142

Batterham RL; Cowley MA; Small CJ; Herzog H; Cohen MA; Dakin CL; Wren AM; Brynes AE; Low MJ; Ghatei MA; Cone RD; Bloom SR, 2004, 'Physiology: Does gut hormone PYY3–36 decrease food intake in rodents?', Nature, 430, http://dx.doi.org/10.1038/nature02666a

Wheway JE; Herzog H; Mackay F, 2004, 'An important role for neuropeptide Y and receptors in regulating adaptive immune responses', Journal of Neuroimmunology, 154, pp. 126 - 126

Molero JC; Jensen T; Withers P; Couzens M; Herzog H; Thien C; Langdon WY; Walder K; Murphy M, 2004, 'c-Cbl-deficient mice have reduced adiposity, higher energy expenditure, and improved peripheral insulin action', Journal of Clinical Investigation, 114, pp. 1326 - 1333, http://www.sciencedirect.com/science/article/B6WVB-4DPKVPD-2S2/2/3e8b10f3525abc50c3927019a8a862ab

Redrobe J; Dumont Y; Herzog H; Quirion R, 2004, 'Characterization of neuropeptide Y,Y-2 receptor knockout mice in twoanimal models of learning and memory processing', Journal of Molecular Neuroscience, 22, pp. 159 - 166

Painsipp E; Wultsch T; Hetzenauer F; Singewald N; Sperk G; Herzog H; Holzer P, 2004, 'Differential changes in homecage activity, baseline temperature andstress-induced hyperthermia in neuropeptide-YY2 and Y-4 receptorknockout mice', Pharmacology, 72, pp. 136 - 136

Allison SJ; Baldock P; Sainsbury A; Enriquez R; Couzens M; Herzog H; Gardiner EM, 2004, 'Distinct Y-receptor effects on leptin antiosteogenic and adipogenic pathways', Journal of Bone and Mineral Research, 19, pp. S27 - S27

Batterham RL; Cowley MA; Small CJ; Herzog H; Cohen MA; Dakin CL; Wren AM; Brynes AE; Low MJ; Ghatei MA; Cone RD; Bloom SR, 2004, 'Does gut hormone PYY3–36 decrease food intake in rodents? (reply)', Nature, 430, pp. 3 - 4, http://dx.doi.org/10.1038/nature02666

Lin S; Boey D; Herzog H, 2004, 'NPY and Y receptors: lessons from transgenic and knockout models', Neuropeptides, 38, pp. 189 - 200, http://www.sciencedirect.com/science/article/B6WNR-4CS4M5B-2/2/709f0f5c8dc06f0a0cd386e61432678a

Baldock P; Allison SJ; Sainsbury A; Lin DE; Enriquez R; During M; Herzog H; Gardiner EM, 2004, 'Pleiotropic responses to hypothalamic neuropeptide Y1 receptor deletion are associated with a high bone mass phenotype', Journal of Bone and Mineral Research, 19, pp. S32 - S32

Herzog H, 2003, 'Neuropeptide Y and energy homeostasis: Insights from Y receptor knockout models', European Journal of Pharmacology, 480, pp. 21 - 29, http://dx.doi.org/10.1016/j.ejphar.2003.08.089

Chu DQ; Cox HM; Costa SKP; Herzog H; Brain SD, 2003, 'The ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: An analysis of the contribution of Y 1 and Y 2 receptors', British Journal of Pharmacology, 140, pp. 422 - 430, http://dx.doi.org/10.1038/sj.bjp.0705452

Howell OW; Scharfman HE; Herzog H; Sundstrom LE; Beck-Sickinger A; Gray WP, 2003, 'Neuropeptide Y is neuroproliferative for post-natal hippocampal precursor cells', Journal of Neurochemistry, 86, pp. 646 - 659, http://dx.doi.org/10.1046/j.1471-4159.2003.01895.x

Sainsbury A; Baldock PA; Schwarzer C; Ueno N; Enriquez RF; Couzens M; Inui A; Herzog H; Gardiner EM, 2003, 'Synergistic effects of Y2 and Y4 receptors on adiposity and bone mass revealed in double knockout mice', Molecular and Cellular Biology, 23, pp. 5225 - 5233, http://dx.doi.org/10.1128/MCB.23.15.5225-5233.2003

Tschenett A; Singewald N; Carli M; Balducci C; Salchner P; Vezzani A; Herzog H; Sperk G, 2003, 'Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors', European Journal of Neuroscience, 18, pp. 143 - 148, http://dx.doi.org/10.1046/j.1460-9568.2003.02725.x

Hyland NP; Sjöberg F; Tough IR; Herzog H; Cox HM, 2003, 'Functional consequences of neuropeptide Y Y 2 receptor knockout and Y 2 antagonism in mouse and human colonic tissues', British Journal of Pharmacology, 139, pp. 863 - 871, http://dx.doi.org/10.1038/sj.bjp.0705298

Redrobe JP; Dumont Y; Herzog H; Quirion R, 2003, 'Neuropeptide Y (NPY) Y2 receptors mediate behaviour in two animal models of anxiety: Evidence from Y2 receptor knockout mice', Behavioural Brain Research, 141, pp. 251 - 255, http://dx.doi.org/10.1016/S0166-4328(02)00374-1


Back to profile page